US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
イギリス
LSE
Firma Oponiarska Debica Sa (0LSR) 銘柄情報

Firma Oponiarska Debica Sa (0LSR)

137.00

0.00

(0.00%)

終了 6月7日 12:30AM

Firma Oponiarska Debica Sa (0LSR) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

137.00

( - )

買値

137.00

売値

137.00

出来高

0.00

0.00 日の範囲 0.00

137.00 52 週間の範囲 137.00

時価総額

前日終値

137.00

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

PLN 1,340

発行済株式数

13,802,750

配当利回り

PER

10.67

1 株当たり利益 (EPS)

8.36

歳入

2.85B

純利益

115.4M

Tire Company Debica S.A. manufactures and sells tires for passenger cars, vans, and trucks under the Debica, Goodyear, Dunlop, Fulda, and Sava brands in Poland. It also offers curing membranes to produce tires. The company exports tires to Luxembourg, Germany, Turkey, the United States, Canada, and ... Tire Company Debica S.A. manufactures and sells tires for passenger cars, vans, and trucks under the Debica, Goodyear, Dunlop, Fulda, and Sava brands in Poland. It also offers curing membranes to produce tires. The company exports tires to Luxembourg, Germany, Turkey, the United States, Canada, and France. The company was formerly known as Firma Oponiarska Debica S.A. Tire Company Debica S.A. was founded in 1937 and is based in Debica, Poland. Tire Company Debica S.A. operates as a subsidiary of Goodyear S.A. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.debica.com.pl

本社

Debica, Poland

設立

2026

Firma Oponiarska Debica Sa is listed in the sector of the ロンドン証券取引所 with ticker 0LSR. The last closing price for Firma Oponiarska Debica was PLN137. Over the last year, Firma Oponiarska Debica shares have traded in a share price range of PLN 137.00 to PLN 137.00.

Firma Oponiarska Debica currently has 13,802,750 shares in issue. The market capitalisation of Firma Oponiarska Debica is PLN1.89 billion. Firma Oponiarska Debica has a price to earnings ratio (PE ratio) of 10.67.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	137	137	137	0	0	DE
26	0	0	137	137	137	0	0	DE
52	0	0	137	137	137	0	0	DE
156	0	0	137	137	137	269	137	DE
260	0	0	137	137	137	157	137	DE

0LSR - Frequently Asked Questions (FAQ)

What is the current Firma Oponiarska Debica Sa share price?

The current share price of Firma Oponiarska Debica Sa is PLN 137.00

How many Firma Oponiarska Debica Sa shares are in issue?

Firma Oponiarska Debica Sa has 13,802,750 shares in issue

What is the market cap of Firma Oponiarska Debica Sa?

The market capitalisation of Firma Oponiarska Debica Sa is PLN 1.89B

What is the 1 year trading range for Firma Oponiarska Debica Sa share price?

Firma Oponiarska Debica Sa has traded in the range of PLN 137.00 to PLN 137.00 during the past year

What is the PE ratio of Firma Oponiarska Debica Sa?

The price to earnings ratio of Firma Oponiarska Debica Sa is 10.67

What is the cash to sales ratio of Firma Oponiarska Debica Sa?

The cash to sales ratio of Firma Oponiarska Debica Sa is 0.43

What is the registered address of Firma Oponiarska Debica Sa?

The registered address for Firma Oponiarska Debica Sa is ul. 1 Maja 1, Debica, 39-200

What is the Firma Oponiarska Debica Sa website address?

The website address for Firma Oponiarska Debica Sa is www.debica.com.pl

weedtrader420

weedtrader420 2分前

☝️🤕🖕🦷🦷🦷🦷

along4zride

along4zride 2分前

You do know new stock symbol will be associated with Fannie Mae if there is IPO right . Best case scenario for hopeful investor based on expected $142 new share IPO if a conversion would be allowed would be at current (FNMA) penny stock price at 23 OTC shares for 1 IPO share.

TieetCoolee

TieetCoolee 3分前

47's floated a sale of 3% to 15% of the 79.9% Government warrant equity. The balance will be allowed to expire while everyone's focused on 2028 elections, watch!

$FMCC~ $FNMA~

skitahoe

skitahoe 4分前

GGB, while I'd love to see someone get the better of Griffin, I doubt if it will cost him more than a couple days pocket change. If people like him, or AdamF ever got jail time for their acts it would be more meaningful. When they pay big penalties, they just become more famous for their misdeeds.

Drugdoctor

Drugdoctor 4分前

Sorry to hear about your comprehension issues. Maybe some memory pills will help with your old age problems.

barnstormer

barnstormer 5分前

Doc, don't know if you saw my recent post to Brazen, but appears we're on the same page here re needing a Flaskworks update.

okpj

At the same time, liquidmetal is recognized as a generic substance. I suppose they could use it accordingly, rather than the trademark?

People say all things about Apple. And I am not happy with all of their practices, but yet admire them for most of their practices.

I

KG21

My bad. I thought since CDH posts the same damn thing over and over and over and over.......that if I posted it a second time.......that maybe we would finally all get it. Did anyone else know that they've missed deadlines. Well, no schit!I know what he's going to post before he ever posts. I think

tisdal

tisdal 15分前

Prophetic Statement (PS): When Zion announces, shareholders will be singing "Happy Days"
CEO : [paraphrase]"I cannot tell how much oil, but we'll be Happy".

PS: There will be a shakeup in the board of directors.
Reality: John Brown dies. He is replaced by Mr. Dunn.

Doc logic

Doc logic 15分前

flipper44,

Time for approval or at least an update on Flaskworks development since the switch to the 2023 model was over two years ago. The last time they went two years on development it was an obvious lack of oversight that allowed an oversized unit to be built or this was done on

TieetCoolee

TieetCoolee 16分前

https://static-assets-1.truthsocial.com/tmtg:prime-ts-assets/media_attachments/files/116/705/027/546/587/180/small/19ea8f22288e98a6.jpg
https://truthsocial.com/@realDonaldTrump/116705027777737558
$FMCC~ $FNMA~

skitahoe

skitahoe 17分前

I'm not disagreeing with what the experts said, it's just a shame that the regulators wanted more of the same to approve it. Companies all too often try to shorten their trials and lower their costs and shoot themselves in the foot by doing so. The question is, would the FDA or any other agency co

manibiotech

manibiotech 19分前

Wow
And that’s why they “ voluntarily “ went to “OTC”
Your BS is so obvious .

wronginvestor

wronginvestor 24分前

If you step back from all the noise this latest PR is incredibly bad. Its full of grammar errors and unfinished sentences.

It confirms they have no banking facilities in the US.

Confirms the judgement.

Confirms they are not going to follow US laws to dea

GoodGuyBill

GoodGuyBill 25分前

Gary, you’re absolutely right about how the SEC treats the OTC. It’s been the financial equivalent of the wild west for years. That’s exactly why this case is so unusual. NWBO isn’t relying on the SEC at all. They went straight to federal court, hired Mitts, and built a record that forces accountabi

Ronnie Replay

Ronnie Replay 28分前

Beware. You are about to get a 15 paragraph response that is mostly copy and pasted.

Eli's Gone

Eli's Gone 29分前

Eli's Gone

Eli's Gone 29分前

ORCA

$3.00 WITH R/S.LMAO.I WILL BE WATCHING MONDAY PREMARKET.AS YOU SAID THIS::::$ILLR_ so why are you guys trying to spin what I’m saying when I said clowns I meant the group of idiots before this CEO came in you guys don’t even realize what is about to happen. OK can’t you read between the lines? Aren’

wronginvestor

wronginvestor 32分前

I think it was aimed at Electric Metals and maybe TAQA to try and keep those deals alive.

However I think it's likely both are dead now. Electric Metals has to make a statement that they got the monies as it's a material event for them. The fact they haven't done so yet speaks volume

ORCA

R/S HAS TO BE IN BY JUNE 30TH.THE ONLY WAY TO REACH $1.00.MONDAY IS THE 8TH.THE TIME IS NEAR.
Los Angeles, June 02, 2026 (GLOBE NEWSWIRE) -- Triller Group Inc (Nasdaq: ILLR; ILLRW) (“Triller” or the “Company”) today announced that, on Friday, May 29, 2026, the Nasdaq Hearings Panel (the “P

skitahoe

skitahoe 36分前

Arguing about the effectiveness of DCVax-L is a fool's errand if you fail to consider what occurs when other therapeutics are added. A 13% survival rate at 5 years is well over the 5% with the SOC, but at UCLA Dr. Liau and her team have pushed it to 50% in a small trial and you know Dr. Liau wants

jbog

Eli Lilly reports broad benefits for experimental obesity drug retatrutide
Jun 06, 2026, 5:37 PM ETEli Lilly and Company (LLY) StockBy: Rob Williams, SA News Editor

Share

Save

Play
(5min)
Comments
(5)
Eli Lilly (LLY) on

Firma Oponiarska Debica

DJ Canada Select Growth

Skyward Specialty Insura...

ALPS Strategic Income

Credit Agricole CIB FCIA...

Agricultural Bank of China

Sequoia Financial

Yancoal Australia

S&P 500 Quarterly Tail H...

iNAV db xtrackers MSCI E...

iNAV dbxtrackers MSCI Br...

Chinese Estates (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。